Symposium:
209. Combination Therapies for Super-Bugs
Saturday, October 7, 2017: 8:30 AM-10:00 AM
Room: 06AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • appraise the current approaches for combination therapy in bacterial and fungal pathogens
  • review the clinical data related to the use of combination therapies in relevant bacterial and fungal pathogens
  • discuss advantages and disadvantages of combination therapy against bacterial and fungal pathogens.

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Researchers, Scientists

Tracks: Trainee, Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID


Moderators:  Cesar Arias, MD, PhD, FIDSA, University of Texas McGovern Medical School , David R. Andes, M.D., FIDSA, University of Wisconsin School of Medicine and Public Health and Robert A. Bonomo, MD, Case Western Reserve University School of Medicine

Presentations:
8:55 AM
Combination Therapies for Gram-Negative Super-Bugs
David Nicolau, PharmD, FCCP, FIDSA

9:20 AM
Combination Therapies for Fungal Pathogens
Luis Ostrosky-Zeichner, MD, FIDSA, FSHEA

9:45 AM
Q&A

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-301-L01-P

Disclosures:

C. Arias, The Medecins Company: Grant Investigator , Research grant
Allergan: Grant Investigator , Research grant
Merck: Grant Investigator , Grant recipient

D. R. Andes, Medicines: Consultant , Consulting fee
Zavante: Consultant and Grant Investigator , Consulting fee and Grant recipient
Paratek: Research Contractor , Research grant
Actelion: Grant Investigator , Grant recipient
Amplyx: Grant Investigator , Grant recipient
Geom: Grant Investigator , Grant recipient
Meiji: Grant Investigator , Grant recipient
Cidaria: Grant Investigator , Grant recipient
Theravance: Consultant and Grant Investigator , Consulting fee and Grant recipient
Astellas: Grant Investigator , Grant recipient

R. A. Bonomo, Entasis: Grant Investigator , Research grant
Allecra: Grant Investigator , Research grant
Wockhardt: Grant Investigator , Research grant
Merck: Grant Investigator , Research grant
Roche: Grant Investigator , Research grant
GSK: Grant Investigator , Research grant
Allergan: Grant Investigator , Research grant
Shionogi: Grant Investigator , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.